Skip to content

XBIOTECH INC.

XBIT

CIK 0001626878

← back to feed
Revenue (TTM)
$1.68M
−100.0% YoY Q1 May 2026
Net Income (TTM)
−$24.15M
−18.2% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.49
−18.3% YoY Q1 May 2026
Gross Margin
87.2%
Q1 May 2026
Operating Margin
-1,917.1%
Q1 May 2026
Net Margin
-1,437.7%
Q1 May 2026
Free Cash Flow (TTM)
−$28.05M
Q1 May 2026
Cash
$115.46M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
30.49M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings